Medexus Pharmaceuticals (MDP.TO) today announced that it has reached an agreement with the provincial government of Quebec for government sponsored coverage of Cuvposa. The glycopyrrolate oral solution will be…
MDP.T
*originally published 01-16-23 Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company. They are not biotech. There is no research and development here. Medexus is all about sales and marketing, bringing…
24 January 2023
Analysts say this specialty pharma stock is on track for…
Chris Parry- MDP.T
Medexus Pharmaceuticals (MDP.T), a Canadian specialty pharma company servicing both the Canadian and American markets, has built a sizeable drug portfolio with continuing growth potential. It’s already been a…
*Originally published 09/28/22 Medexus Pharmaceuticals (MDP.T), is a Canadian-based specialty pharma firm focused on bringing already approved drugs from different regulatory jurisdictions into the Canadian and American market. Medexus…
Medexus Pharmaceuticals (MDP.T), a Canadian specialty pharma company servicing both the Canadian and American markets, has built a sizeable drug portfolio with continuing growth potential. It’s already been a…
Medexus Pharmaceuticals (MDP.T), a Canadian specialty pharma company focused on the North American markets, has developed a robust drug portfolio that still has lots of room for growth. Due…
Medexus Pharmaceuticals (MDP.TO) today announced preliminary estimates of the company’s revenue results for the quarter ended December 31st 2022 (fiscal Q3 2023). After Q2 2023 being Medexus’ strongest quarter…
Medexus Pharma (MDP.T) doesn’t have long to go before the release of its next quarterly financials and news could be good. Investors have previously missed the opportunity behind Medexus…
Specialty pharma company Medexus Pharmaceuticals (MDP.TO) announced today that it plans to host a conference call at 8:00 am EST on Wednesday November 9th 2022. The call will discuss…
Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company that has been making big moves on the charts. The company is not a biotech company. They do not do research…